Freda C. Lewis-Hall - Insider Trading & Ownership

Entity
Individual
Location
C/O Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, MA
Summary
The estimated net worth of Freda C. Lewis-Hall is at least $2.98M dollars as of May 17, 2024. Freda C. Lewis-Hall is the Director of EXACT SCIENCES CORP and owns shares of EXACT SCIENCES CORP (EXAS) stock worth about $1.45M. Freda C. Lewis-Hall is the Director of SpringWorks Therapeutics, Inc. and owns shares of SpringWorks Therapeutics, Inc. (SWTX) stock worth about $698K. Freda C. Lewis-Hall is the Director of CONDUIT PHARMACEUTICALS INC. and owns shares of CONDUIT PHARMACEUTICALS INC. (CDT) stock worth about $492K. Freda C. Lewis-Hall is the Director of Pyxis Oncology, Inc. and owns shares of Pyxis Oncology, Inc. (PYXS) stock worth about $338K.
All Insider Reports
All Insider Reports

Ownership of Freda C. Lewis-Hall

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EXAS EXACT SCIENCES CORP Director $1.45M Jun 8, 2023
SWTX SpringWorks Therapeutics, Inc. Director $698K May 16, 2024
CDT, CDTTW CONDUIT PHARMACEUTICALS INC. Director $492K Apr 22, 2024
PYXS Pyxis Oncology, Inc. Director $338K Mar 26, 2024
ONEM 1Life Healthcare Inc Director Feb 22, 2023

Insider Transactions Reported by Freda C. Lewis-Hall:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.